Obiltoxaximab: First Global Approval
Crossref DOI link: https://doi.org/10.1007/s40265-016-0577-0
Published Online: 2016-04-16
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Greig, Sarah L.
Text and Data Mining valid from 2016-04-16
